Open AccessMucormycosis in COVID 19 patients: A review
Author(s) -
P Sachidananda Mallya,
Shrikara Mallya
Publication year - 2021
Publication title -
biomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 9
ISSN - 0970-2067
DOI - 10.51248/.v41i3.1191
Subject(s) - covid-19 , medicine , etiology , mucormycosis , population , dermatology , disease , perforation , surgery , intensive care medicine , pathology , environmental health , materials science , punching , metallurgy , infectious disease (medical specialty)
not only worried about this fatal communicable virus but also other difficulties that are being declared by the patients.One such deadly problem being reported in patients in India in current times, who have produced positive result for COVID-19 and are slowly regaining health, is a fungal disease called mucormycotic or black fungus. With many such cases being announced incities and states like Mumbai Bengaluru, Delhi, and Gujarat it has provoked an extra wave of fear among the general population.Mucormycosis, previouslycalledaszygomycosis, is an uncommon fungal infection. It is caused by the mould related to mucorales, that is found mainly in decayed wood organic matters soil and leaves. They can cause blackening of skin, redness, inflammation,sores and can encroach the eyes, lungs and even the brain, substantiating to be dangerous if left without treatment. So, it is necessary to knowthe etiological factors and prominent symptoms associated withclinical implications of mucormycosismainly invasiveness and perforation into deeper part of the bone.That is why it is necessary to identify immediately any possible badsigns of mucormycosisarising in both, COVID-19 patients, and other individuals. The report must be communicated to the healthcare workerswithout delay so that treatment can be provided at a suitable time and the patient recovers completely.